National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting, 16950 [2020-06204]

Download as PDF 16950 Federal Register / Vol. 85, No. 58 / Wednesday, March 25, 2020 / Notices COVID–19-related guidance documents. All COVID–19-related guidance documents issued by that Center or Office will be available in the docket associated with the Center or Office that issues the guidance document. The docket numbers associated with each Center or Office that may issue COVID– 19-related guidance documents are as follows: Title of Docket (for each Center or Office) Docket No. Center for Drug Evaluation and Research (CDER) COVID–19 .............................................................................................. Center for Biologics Evaluation and Research (CBER) COVID–19 ....................................................................................... Center for Devices and Radiological Health (CDRH) COVID–19 ........................................................................................... Center for Food Safety and Applied Nutrition (CFSAN) COVID–19 ....................................................................................... Center for Veterinary Medicine (CVM) COVID–19 ................................................................................................................. Center for Tobacco Products (CTP) COVID–19 ..................................................................................................................... Office of the Commissioner (OC) COVID–19 ......................................................................................................................... Office of Regulatory Affairs (ORA) COVID–19 ....................................................................................................................... Dated: March 20, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–06222 Filed 3–20–20; 11:15 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of General Medical Sciences Special Emphasis Panel, April 3, 2020, 8:00 a.m. to April 3, 2020, 6:00 p.m., The Hyatt House, Potomac Conference Room, The Wharf, 725 Wharf Street SW, Washington, DC 20024 which was published in the Federal Register on December 19, 2019, 84 FR 69756. The meeting notice is amended to change the Meeting Format from Regular Meeting on April 3, 2020 to a Teleconference Meeting on April 3, 2020. The meeting is closed to the public. Dated: March 19, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–06203 Filed 3–24–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES khammond on DSKJM1Z7X2PROD with NOTICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Subcommittee A— Cancer Centers, May 13, 2020, 5:00 p.m. to May 14, 2020, 6:00 p.m., Embassy Suites at the Chevy Chase Pavilion, VerDate Sep<11>2014 16:18 Mar 24, 2020 Jkt 250001 4300 Military Road NW, Washington, DC 20015 which was published in the Federal Register on December 20, 2019, 84 FR 70202. This meeting notice is amended to change the meeting location, times, and format. The meeting will now be held on May 13, 2020, 9:00 a.m. to May 14, 2020, 11:30 a.m. as a Video-Assisted Meeting at National Cancer Institute (NCI) Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850. The meeting is closed to the public. Dated: March 19, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–06201 Filed 3–24–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, April 14, 2020, 08:00 a.m. to April 14, 2020, 05:00 p.m., Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), Conference Room Auburn, 8120 Wisconsin Avenue, Bethesda, MD 20814 which was published in the Federal Register on March 09, 2020, 85 FR 13667. The meeting notice is amended to change the Meeting Format from Regular Meeting on April 14, 2020 to a Teleconference Meeting on April 14, 2020. The meeting is closed to the public. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 FDA–2020–D–1136 FDA–2020–D–1137 FDA–2020–D–1138 FDA–2020–D–1139 FDA–2020–D–1140 FDA–2020–D–1141 FDA–2020–D–1142 FDA–2020–D–1143 Dated: March 19, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–06204 Filed 3–24–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Advisory Council, March 30, 2020, 8:30 a.m. to 3:00 p.m. at National Institutes of Health, 6700B Rockledge Drive, Conference Room A&B, Bethesda, MD 20817 which was published in the Federal Register on January 30, 2020, 85 FR 5459, and change in format published in the Federal Register on March 17, 2020, 85 FR 15206. The meeting will be held at National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, March 30, 2020, 1:00 p.m. to 3:00 p.m. This meeting will be held by videoconference only. URL for virtual access: https:// videocast.nih.gov. For additional information, please visit: https://public.csr.nih.gov/ AboutCSR/Organization/CSRAdvisory Council. The meeting is open to the public. Dated: March 19, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–06209 Filed 3–24–20; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\25MRN1.SGM 25MRN1

Agencies

[Federal Register Volume 85, Number 58 (Wednesday, March 25, 2020)]
[Notices]
[Page 16950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06204]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Diabetes and Digestive and Kidney Diseases Special 
Emphasis Panel, April 14, 2020, 08:00 a.m. to April 14, 2020, 05:00 
p.m., Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 
Conference Room Auburn, 8120 Wisconsin Avenue, Bethesda, MD 20814 which 
was published in the Federal Register on March 09, 2020, 85 FR 13667.
    The meeting notice is amended to change the Meeting Format from 
Regular Meeting on April 14, 2020 to a Teleconference Meeting on April 
14, 2020. The meeting is closed to the public.

    Dated: March 19, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-06204 Filed 3-24-20; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.